Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Saturday, June 15, 2024 | Back issues
Courthouse News Service Courthouse News Service

Big Pharma

Allergan faces a federal class action alleging that the pharmaceutical giant's two retirement plans wasted assets by buying inflated Allergan stock.

NEWARK, N.J. – Allergan, the pharmaceutical giant previously known as Actavis, faces a federal class action alleging that two retirement plans wasted assets by buying inflated Allergan stock.

Categories / Employment, Securities

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...